Anti-EBOV GP Neutralizing Antibody (V3S-0723-FY201) (CAT#: V3S-0723-FY201)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description #3327 antibody is a recombinant mouse antibody that specifically targets the Ebola Virus (EBOV) GP protein. #3327 exhibits potent neutralizing activity against the ebolavirus. #3327 can be utilized in ELISA assays with a concentration of 100 μg/ml and possesses a 50% neutralization titer of 4 μg/ml.
Clonality Monoclonal
Host Species Mouse
Target Species Ebola Virus (EBOV)
Isotype IgG1, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein G purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application Neut; ELISA; FC
Application Notes ELISA: 100 μg/ml
Neutralization assay: This antibody possesses a 50% neutralization titer of 4 μg/ml.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target EBOV GP
Alternative Name Ebola Virus Glycoprotein; Ebola Virus
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry